Biotissue, TransTissue Technologies GmbH deal

BTS acquired the remaining 37.4% of TransTissue that it did not already own for 79,534 shares. TransTissue, a spinoff of the Charité Medical Faculty of Berlin's Humboldt University, develops autologou...